Siloam Hospitals and Roche Indonesia have announced a strategic partnership to enhance breast cancer care standards in the country. The collaboration focuses on improving early detection, treatment options, and patient support for women affected by breast cancer.
Breast cancer remains the most common cancer among women in Indonesia, with approximately 66,000 new cases diagnosed each year. The partnership aims to address gaps in diagnosis and treatment access, particularly in rural areas where healthcare resources are limited.
Roche Indonesia will provide advanced diagnostic tools and therapeutic solutions, while Siloam Hospitals will offer clinical expertise and infrastructure. The initiative also includes training programs for medical professionals to improve care quality.
The collaboration is expected to benefit thousands of women by increasing access to timely and effective treatment. Both organizations emphasize the importance of raising awareness and reducing the stigma surrounding breast cancer in the region.
